25696-60-0 Usage
Uses
Used in Pharmaceutical Industry:
2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid is used as a pharmaceutical candidate for the development of new drugs. Its unique structure and functional groups allow it to interact with various biological targets, making it a promising compound for the treatment of various diseases.
Used in Cholestasis Studies:
In the field of hepatology, 2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid may be used for studying cholestasis, a condition characterized by the impaired flow of bile. Its structural similarities to bile acids, such as Tauro-β-Muricholic Acid, could make it a useful tool for understanding the underlying mechanisms of this condition and potentially developing new therapeutic strategies.
Used in Drug Delivery Systems:
Similar to gallotannin, 2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid could be employed in the development of novel drug delivery systems. Its unique structure and functional groups may allow for improved targeting and delivery of therapeutic agents, enhancing their efficacy and reducing side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 25696-60-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,9 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 25696-60:
(7*2)+(6*5)+(5*6)+(4*9)+(3*6)+(2*6)+(1*0)=140
140 % 10 = 0
So 25696-60-0 is a valid CAS Registry Number.
25696-60-0Relevant academic research and scientific papers
INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE
-
Paragraph 0358; 0359, (2015/02/25)
Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R1, R2, R4, X, Y, Z, m, and n are as defined herein, which are useful in treating or preventing obesity, type 2 diabetes/insulin resistance and non alcoholic fatty liver disease in a mammal in need thereof. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, a method of method of inhibiting a farnesoid X receptor in a mammal, and a method of treating or preventing obesity in a mammal.
